GenMark Diagnostics Inc. (GNMK) announced after the bell Monday that it now expects to report full year 2013 revenues of approximately $30 million, down from its original estimate of approximately $35 million. The consensus estimate is for revenues of $35.11 million. The stock is now down 0.72 on 36K shares.
GenMark Diagnostics traded to the downside throughout Monday's session and finished lower by 1 point at $10.97. The stock has been steadily declining for the past week.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.